Post-MI Follow-up

Cardiology

Secondary prevention after acute coronary syndrome.

History taking

  • Onset, duration, progression, severity
  • Aggravating / relieving factors
  • Past history, drugs, allergies, comorbidities
  • Family & social history relevant to presentation

Examination

  • General: vitals, pallor, icterus, oedema, lymphadenopathy
  • Focused system examination
  • Look for red-flag findings

Red flags

  • Haemodynamic instability
  • Rapid deterioration
  • Severe pain or new neurological deficit

Differential diagnosis

  • See differentials section per chief complaint

Recommended investigations

  • CBC, basic metabolic panel as indicated
  • Targeted disease-specific tests

Diagnosis

  • Clinical diagnosis supported by targeted investigations

Initial treatment / management

  • Treat underlying cause
  • Symptomatic relief
  • Patient education

Drug therapy

  • Aspirin 75 mg OD lifelong + P2Y12 inhibitor 12 months
  • High-intensity statin
  • ACEi/ARB
  • β-blocker ≥1 year
  • MRA if EF <40 + HF/DM

Lifestyle advice

  • Cardiac rehab, smoking cessation, Mediterranean diet

Follow-up advice

  • 6-week, 3-month, 12-month review
  • Echo at 6–12 weeks

Patient counselling

  • Explain diagnosis and natural course in lay terms
  • Red-flag symptoms warranting urgent return
  • Adherence to medications and follow-up

Referral criteria

  • Refer if diagnostic uncertainty, complications, or failure of first-line therapy

References

  • Harrison's Principles of Internal Medicine, 21e
  • NICE / WHO guidelines (current edition)

Educational outpatient guide — verify against local guidelines before clinical use.

WardRound

WardRound

Clinical Decisions in Seconds